Maynard Um
-
-
-
-
-
-
-
LENZ Therapeutics Inc (LENZ) PT Lowered to $20 at Citi
-
-
-
-
-
-
-
LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 116c
-
-
-
-
-
-
-
LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c
-
-
-
-
-
-
-
LENZ Therapeutics Inc (LENZ) PT Raised to $56 at H.C. Wainwright
-
-
-
-
-
-
-
LENZ Therapeutics (LENZ) and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
-
-
-
-
-
-
-
LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c
-
-
-
-
-
-
-
LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 40c
-
435,380 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

